Bristol's New Chief Scientific Officer Lists Oncology Priorities, But Little New

 
• By Lucie Ellis-Taitt
  
BMY Chief Scientific Officer Thomas Lynch
BMS chief scientific officer Thomas Lynch reels off list of R&D priorities on ASCO call
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business